Compare SCLX & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | PPSI |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 30.1M |
| IPO Year | 2020 | 2008 |
| Metric | SCLX | PPSI |
|---|---|---|
| Price | $2.06 | $2.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 40.4K | ★ 69.9K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | $27,627,000.00 |
| Revenue This Year | $118.16 | N/A |
| Revenue Next Year | $186.31 | $35.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.75 |
| 52 Week Low | $2.27 | $2.20 |
| 52 Week High | $27.00 | $6.29 |
| Indicator | SCLX | PPSI |
|---|---|---|
| Relative Strength Index (RSI) | 14.46 | 41.49 |
| Support Level | N/A | $2.35 |
| Resistance Level | $7.77 | $3.50 |
| Average True Range (ATR) | 0.23 | 0.17 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 2.53 | 48.05 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. The Company launched two new product platforms namely, PRYMUS, a new, mobile on-site power system concentrating on customers with requirements of 1-10 megawatts of mobile power and PowerCore, a residential and small commercial based primary generator system integrating a DC fast charger into one solution.